| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Casting light on molecular events underlying anti-cancer drug treatment: What can be seen from the proteomics point of view?
|
Kraljevic, Sandra
|
|
2006
|
32 |
8 |
p. 619-629
11 p.
|
artikel
|
| 2 |
Chemotherapeutic agents for colorectal cancer with a defective mismatch repair system: The state of the art
|
Valentini, Anna Maria
|
|
2006
|
32 |
8 |
p. 607-618
12 p.
|
artikel
|
| 3 |
Clinical review – Small cell carcinoma of the bladder
|
Church, David N.
|
|
2006
|
32 |
8 |
p. 588-593
6 p.
|
artikel
|
| 4 |
Commentary: Concomitant chemotherapy and radiation for limited stage small cell lung cancer and benefit of adding additional drug into chemotherapy regimen for advanced non-small cell lung cancer
|
Tanvetyanon, Tawee
|
|
2006
|
32 |
8 |
p. 656-657
2 p.
|
artikel
|
| 5 |
Editorial board
|
|
|
2006
|
32 |
8 |
p. CO2-
1 p.
|
artikel
|
| 6 |
Evidence profiles for lung cancer: Benefit/harms data based on the totality of randomized evidence
|
Soares, Heloisa P.
|
|
2006
|
32 |
8 |
p. 652-655
4 p.
|
artikel
|
| 7 |
Perspectives for targeted therapies in cancer of unknown primary site
|
Pentheroudakis, George
|
|
2006
|
32 |
8 |
p. 637-644
8 p.
|
artikel
|
| 8 |
Radiation therapy-induced mucositis: Relationships between fractionated radiation, NF-κB, COX-1, and COX-2
|
Yeoh, Ann
|
|
2006
|
32 |
8 |
p. 645-651
7 p.
|
artikel
|
| 9 |
Targeted therapy in advanced non-small cell lung cancer (NSCLC): Where do we stand?
|
Azim Jr., Hatem A.
|
|
2006
|
32 |
8 |
p. 630-636
7 p.
|
artikel
|
| 10 |
Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies
|
Marelli, Laura
|
|
2006
|
32 |
8 |
p. 594-606
13 p.
|
artikel
|
| 11 |
Weekly docetaxel as second line chemotherapy for advanced non-small-cell lung cancer: Meta-analysis of randomized trials
|
Bria, Emilio
|
|
2006
|
32 |
8 |
p. 583-587
5 p.
|
artikel
|
Tijdschrift beschrijving